inflammation panel Search Results


electrodes  (KCAS Bioanalytical and Biomarker Services)
94
KCAS Bioanalytical and Biomarker Services electrodes
Electrodes, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrodes/product/KCAS Bioanalytical and Biomarker Services
Average 94 stars, based on 1 article reviews
electrodes - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
human cytokine inflammation 9 plex kit  (Quansys Biosciences)
92
Quansys Biosciences human cytokine inflammation 9 plex kit
Human Cytokine Inflammation 9 Plex Kit, supplied by Quansys Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cytokine inflammation 9 plex kit/product/Quansys Biosciences
Average 92 stars, based on 1 article reviews
human cytokine inflammation 9 plex kit - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
kcas bio analytical  (KCAS Bioanalytical and Biomarker Services)
99
KCAS Bioanalytical and Biomarker Services kcas bio analytical
Kcas Bio Analytical, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kcas bio analytical/product/KCAS Bioanalytical and Biomarker Services
Average 99 stars, based on 1 article reviews
kcas bio analytical - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
human inflammationmap multiplex assay  (Myriad RBM)
90
Myriad RBM human inflammationmap multiplex assay
Human Inflammationmap Multiplex Assay, supplied by Myriad RBM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human inflammationmap multiplex assay/product/Myriad RBM
Average 90 stars, based on 1 article reviews
human inflammationmap multiplex assay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
targeted human inflammation and immunity transcriptome panel  (Qiagen)
90
Qiagen targeted human inflammation and immunity transcriptome panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Targeted Human Inflammation And Immunity Transcriptome Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/targeted human inflammation and immunity transcriptome panel/product/Qiagen
Average 90 stars, based on 1 article reviews
targeted human inflammation and immunity transcriptome panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ncounter ® human inflammation v2 panel  (Bruker Corporation)
90
Bruker Corporation ncounter ® human inflammation v2 panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Ncounter ® Human Inflammation V2 Panel, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ncounter ® human inflammation v2 panel/product/Bruker Corporation
Average 90 stars, based on 1 article reviews
ncounter ® human inflammation v2 panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
immune and inflammation snp panel  (ParAllele BioScience Inc)
90
ParAllele BioScience Inc immune and inflammation snp panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Immune And Inflammation Snp Panel, supplied by ParAllele BioScience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immune and inflammation snp panel/product/ParAllele BioScience Inc
Average 90 stars, based on 1 article reviews
immune and inflammation snp panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
customized qiaseq targeted rna panel (human inflammation and immunity transcriptome panel)  (Qiagen)
90
Qiagen customized qiaseq targeted rna panel (human inflammation and immunity transcriptome panel)
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Customized Qiaseq Targeted Rna Panel (Human Inflammation And Immunity Transcriptome Panel), supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/customized qiaseq targeted rna panel (human inflammation and immunity transcriptome panel)/product/Qiagen
Average 90 stars, based on 1 article reviews
customized qiaseq targeted rna panel (human inflammation and immunity transcriptome panel) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nulisaseq 200-plex inflammation panel  (Illumina Inc)
90
Illumina Inc nulisaseq 200-plex inflammation panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Nulisaseq 200 Plex Inflammation Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nulisaseq 200-plex inflammation panel/product/Illumina Inc
Average 90 stars, based on 1 article reviews
nulisaseq 200-plex inflammation panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
cancer inflammation and immunity crosstalk qiagen rt2 profiler panel  (Qiagen)
90
Qiagen cancer inflammation and immunity crosstalk qiagen rt2 profiler panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Cancer Inflammation And Immunity Crosstalk Qiagen Rt2 Profiler Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cancer inflammation and immunity crosstalk qiagen rt2 profiler panel/product/Qiagen
Average 90 stars, based on 1 article reviews
cancer inflammation and immunity crosstalk qiagen rt2 profiler panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
inflammation panel testing  (Cleveland HeartLab)
90
Cleveland HeartLab inflammation panel testing
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Inflammation Panel Testing, supplied by Cleveland HeartLab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inflammation panel testing/product/Cleveland HeartLab
Average 90 stars, based on 1 article reviews
inflammation panel testing - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
immune and inflammation panel  (ParAllele BioScience Inc)
90
ParAllele BioScience Inc immune and inflammation panel
Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the <t>transcriptome</t> analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.
Immune And Inflammation Panel, supplied by ParAllele BioScience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immune and inflammation panel/product/ParAllele BioScience Inc
Average 90 stars, based on 1 article reviews
immune and inflammation panel - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the transcriptome analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.

Journal: Nature Communications

Article Title: Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia

doi: 10.1038/s41467-024-48259-4

Figure Lengend Snippet: Validation of the RNA-Seq results was performed by comparing the significant ( p < 0.050) DEGs in the transcriptome analysis with those that were significant in a Qiagen targeted-RNA sequencing panel (491 immune response genes) in a different cohort of Kenyan children [SMA ( n = 21) and non-SMA ( n = 23). a Heatmap illustrating the comparison of significant ( p < 0.050) DEGs between the two datasets. The Y-axis depicts the gene pairs, and the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ). Statistical significance determined using a generalized linear model with a negative binomial distribution, p < 0.050. b Correlation scatter plot demonstrating the relationship between significantly expressed genes in targeted QIAseq analysis (Log 2 FoldChange, Y-axis) versus transcriptome data (Log 2 FoldChange, X-axis). A strong positive correlation of DEGs using two-tailed Spearman’s test ( r = 0.612; 95% confidence interval, 0.496-0.706; p = 1.842E−16) validates concordance between the two sequencing methods.

Article Snippet: Total RNA (125 ng) was used to synthesize cDNA using the First Strand Kit reagents (Qiagen) specific for the Targeted Human Inflammation and Immunity Transcriptome Panel (RHS-005Z, Qiagen).

Techniques: Biomarker Discovery, RNA Sequencing, Comparison, Two Tailed Test, Sequencing

To assess the alignment between DEGs identified from RNA-Seq and changes in protein levels, whole blood transcriptome data were compared with protein abundance measured in plasma using a 7k SomaScan platform. MetaCore TM facilitated the mapping of genes to their respective protein products for 35 children (n = 19 non-SMA and n = 16 SMA) with both available measurements. The analysis identified 405 gene/protein pairs with a significant association ( p < 0.050). a Heatmap showing the comparison of significant ( p < 0.050) gene/protein pairs between the two datasets. The Y-axis depicts the gene/protein pairs, while the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ), and p < 0.050 calculated using a generalized linear model with a negative binomial distribution. b Correlation scatter plot demonstrating the relationship between significantly expressed protein targets (Log 2 FoldChange; Y-axis) and genes (Log 2 FoldChange; X-axis). A two-tailed Spearman’s test indicated a modest positive concordance between gene expression and protein abundance ( r = 0.205; 95% confidence interval, 0.107–0.299); p = 3.200E−5].

Journal: Nature Communications

Article Title: Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia

doi: 10.1038/s41467-024-48259-4

Figure Lengend Snippet: To assess the alignment between DEGs identified from RNA-Seq and changes in protein levels, whole blood transcriptome data were compared with protein abundance measured in plasma using a 7k SomaScan platform. MetaCore TM facilitated the mapping of genes to their respective protein products for 35 children (n = 19 non-SMA and n = 16 SMA) with both available measurements. The analysis identified 405 gene/protein pairs with a significant association ( p < 0.050). a Heatmap showing the comparison of significant ( p < 0.050) gene/protein pairs between the two datasets. The Y-axis depicts the gene/protein pairs, while the X-axis represents the assay type. The color scale depicts fold regulation (Log 2 ), and p < 0.050 calculated using a generalized linear model with a negative binomial distribution. b Correlation scatter plot demonstrating the relationship between significantly expressed protein targets (Log 2 FoldChange; Y-axis) and genes (Log 2 FoldChange; X-axis). A two-tailed Spearman’s test indicated a modest positive concordance between gene expression and protein abundance ( r = 0.205; 95% confidence interval, 0.107–0.299); p = 3.200E−5].

Article Snippet: Total RNA (125 ng) was used to synthesize cDNA using the First Strand Kit reagents (Qiagen) specific for the Targeted Human Inflammation and Immunity Transcriptome Panel (RHS-005Z, Qiagen).

Techniques: RNA Sequencing, Quantitative Proteomics, Clinical Proteomics, Comparison, Two Tailed Test, Gene Expression